The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Saved by the Nose: Bystander-Administered Intranasal Naloxone Hydrochloride for Opioid Overdose
Open accessAbstract
Administering naloxone hydrochloride (naloxone) during an opioid overdose reverses the overdose and can prevent death. Although typically delivered via intramuscular or intravenous injection, naloxone may be delivered via intranasal spray device. In August 2006, the Boston Public Health Commission passed a public health regulation that authorized an opioid overdose prevention program that included intranasal naloxone education and distribution of the spray to potential bystanders. Participants were taught by trained nonmedical needle exchange staff. After 15 months, the program provided training and intranasal naloxone to 385 participants who reported 74 successful overdose reversals. Problems with intranasal naloxone were uncommon. Overdose prevention education with distribution of intranasal naloxone is a feasible public health intervention to address opioid overdose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This route of administration has been validated for both OT (6, 71) and NAL (72–74) in previous human studies”
From Oxytocin under opioid antagonism leads to supralinear enhancement of social attention (2017) · cites this paper as [74]
Citations
Cites
Increasing deaths from opioid analgesics in the United States
Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1276 · Cited by 696
Seal, K. H. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti053 · Cited by 244
Prescribing Naloxone to Actively Injecting Heroin Users: A Program to Reduce Heroin Overdose Deaths
Maxwell, S., Bigg, D., Stanczykiewicz, K., & Carlberg-Racich, S. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n03_11 · Cited by 242
Green, T. C., Heimer, R. R., & Grau, L. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02182.x · Cited by 192
Kelly, A., Kerr, D. C., Koutsogiannis, Z., Dietze, P., Patrick, I., & Walker, T. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06550.x · Cited by 163
Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes
Dettmer, K., Saunders, B., & Strang, J. (2001) · BMJ · doi:10.1136/bmj.322.7291.895 · Cited by 158
Tobin, K. E., Sherman, S. G., Beilenson, P. L., Welsh, C., & Latkin, C. A. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.03.002 · Cited by 149
Take‐home naloxone to reduce heroin death
Baca, C. T., & Grant, K. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01259.x · Cited by 137
Barton, E. D., Colwell, C. B., Wolfe, T. R., Fosnocht, D., Gravitz, C. S., Bryan, T. S., Dunn, W., Benson, J., & Bailey, J. E. (2005) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2005.03.007 · Cited by 136
Galea, S., Worthington, N., Piper, T. M., Nandi, V., Curtis, M., & ROSENTHAL, D. M. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.07.020 · Cited by 131
Research works printed but not linked: 5
- Centers for Disease Control and Prevention, 2000, MMWR Morb Mortal Wkly Rep, 49, 636
- Centers for Disease Control and Prevention, 2000, MMWR Morb Mortal Wkly Rep, 49, 633
- Sherman SG, Int J Drug Policy
- Tobin KE, Int J Drug Policy
- Davis JE, 2008, J Emerg Med
Cited by
Sorted by citations
Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999
A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs
Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000034 · Cited by 490
McDonald, R., & Strang, J. (2016) · Addiction · doi:10.1111/add.13326 · Cited by 472
Naloxone dosage for opioid reversal: current evidence and clinical implications
Lynn, R. R., & Galinkin, J. L. (2017) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098617744161 · Cited by 363
Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal
Coffin, P. O., & Sullivan, S. D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-1-201301010-00003 · Cited by 347
Binswanger, I. A., Nowels, C., Corsi, K. F., Glanz, J., Long, J., Booth, R. E., & Steiner, J. F. (2012) · Addiction Science & Clinical Practice · doi:10.1186/1940-0640-7-3 · Cited by 329
The Opioid Epidemic: Crisis and Solutions
Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052534 · Cited by 307
Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’
Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.004 · Cited by 291
Part 10: Special Circumstances of Resuscitation
Lavonas, E. J., Drennan, I. R., Gabrielli, A., Heffner, A. C., Hoyte, C. O., Orkin, A. M., Sawyer, K. N., & Donnino, M. W. (2015) · Circulation · doi:10.1161/cir.0000000000000264 · Cited by 276
Fairbairn, N. S., Coffin, P. O., & Walley, A. Y. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.005 · Cited by 288
Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.001 · Cited by 272
Community-Based Opioid Overdose Prevention Programs Providing Naloxone —United States, 2010
Wheeler, E., Davidson, P. J., Jones, T. S., & Irwin, K. S. (2012) · JAMA · doi:10.1001/jama.307.13.1358 · Cited by 257
Unick, G. J., Rosenblum, D., Mars, S. G., & Ciccarone, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054496 · Cited by 255
Mueller, S. R., Walley, A. Y., Calcaterra, S. L., Glanz, J. M., & Binswanger, I. A. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1010032 · Cited by 193
Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
Enteen, L., Bauer, J., McLean, R., Wheeler, E., Huriaux, E., Kral, A. H., & Bamberger, J. D. (2010) · Journal of Urban Health · doi:10.1007/s11524-010-9495-8 · Cited by 185
Kerr, D. C., Kelly, A., Dietze, P., Jolley, D., & Barger, B. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02724.x · Cited by 175
Doe-Simkins, M., Quinn, E. K., Xuan, Z., Sorensen-Alawad, A., Hackman, H., Ozonoff, A., & Walley, A. Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-297 · Cited by 175
Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo, B. (2016) · Addiction · doi:10.1111/add.13741 · Cited by 174
Friedman, J. R., & Akre, S. (2021) · American Journal of Public Health · doi:10.2105/ajph.2021.306256 · Cited by 168
Legal changes to increase access to naloxone for opioid overdose reversal in the United States
Davis, C. S., & Carr, D. H. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.013 · Cited by 166
Wermeling, D. P. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614564776 · Cited by 164
The Opioid Epidemic in the United States
Wilkerson, R. G., Kim, H., Windsor, T. A., & Mareiniss, D. P. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2015.11.002 · Cited by 161
McDonald, R., CAMPBELL, N. D., & Strang, J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.001 · Cited by 147
Banta‐Green, C. J., Beletsky, L. A., Schoeppe, J. A., Coffin, P. O., & Kuszler, P. C. (2013) · Journal of Urban Health · doi:10.1007/s11524-013-9814-y · Cited by 140
Frank, D., Mateu‐Gelabert, P., Guarino, H., Bennett, A. S., Wendel, T., Jessell, L., & Teper, A. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.07.013 · Cited by 130
Bohnert, A. S. B., Bonar, E. E., Cunningham, R., Greenwald, M. K., Thomas, L., Chermack, S., Blow, F. C., & Walton, M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.018 · Cited by 123
Binswanger, I. A., Koester, S. K., Mueller, S. R., Gardner, E. M., Goddard, K., & Glanz, J. M. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3394-3 · Cited by 129
Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD
Mars, S. G., Ondocsin, J., & Ciccarone, D. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1394508 · Cited by 127
Strang, J., McDonald, R., Campbell, G., Degenhardt, L. J., Nielsen, S., Ritter, A. J., & Dale, O. (2019) · Drugs · doi:10.1007/s40265-019-01154-5 · Cited by 136
Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses
Lankenau, S. E., Wagner, K. D., Silva, K., Kecojević, A., Iverson, E., McNeely, M., & Kral, A. H. (2012) · Journal of Community Health · doi:10.1007/s10900-012-9591-7 · Cited by 123
Treatment of overdose in the synthetic opioid era
Skolnick, P. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108019 · Cited by 123
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
Green, T. C., Dauria, E., Bratberg, J. P., Davis, C. S., & Walley, A. Y. (2015) · Harm Reduction Journal · doi:10.1186/s12954-015-0058-x · Cited by 114
Impact of a community-based naloxone distribution program on opioid overdose death rates
Naumann, R. B., Durrance, C. P., Ranapurwala, S. I., Austin, A. E., Proescholdbell, S., Childs, R., Marshall, S. W., Kansagra, S., & Shanahan, M. E. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.038 · Cited by 112
Krieter, P. A., Chiang, N., Gyaw, S., Skolnick, P., Crystal, R., Keegan, F., Aker, J., Beck, M., & Harris, J. J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.759 · Cited by 111
Williams, A., Marsden, J., & Strang, J. (2013) · Addiction · doi:10.1111/add.12360 · Cited by 109
Opioid overdose prevention with intranasal naloxone among people who take methadone
Walley, A. Y., Doe-Simkins, M., Quinn, E., Pierce, C., Xuan, Z., & Ozonoff, A. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.07.004 · Cited by 107
Prevention of Fatal Opioid Overdose
Beletsky, L. A., Rich, J. D., & Walley, A. Y. (2012) · JAMA · doi:10.1001/jama.2012.14205 · Cited by 103
HIV infection and risk of overdose
Green, T. C., McGowan, S. K., Yokell, M. A., Pouget, E. R., & Rich, J. D. (2011) · AIDS · doi:10.1097/qad.0b013e32834f19b6 · Cited by 103
Naloxone for Opioid Overdose Prevention
Bailey, A. M., & Wermeling, D. P. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014523730 · Cited by 102
McDonald, R., Lorch, U., Woodward, J., Bosse, B., Dooner, H., Mundin, G., Smith, K. J., & Strang, J. (2017) · Addiction · doi:10.1111/add.14033 · Cited by 98
Opioid overdose detection using smartphones
Nandakumar, R., Gollakota, S., & Sunshine, J. E. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau8914 · Cited by 102
Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
Mars, S. G., Ondocsin, J., & Ciccarone, D. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0232-z · Cited by 96
Brief overdose education is sufficient for naloxone distribution to opioid users
Behar, E., Santos, G., Wheeler, E., Rowe, C. L., & Coffin, P. O. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.12.009 · Cited by 95
Faul, M., Dailey, M. W., Sugerman, D. E., Sasser, S. M., Levy, B., & Paulozzi, L. J. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.302520 · Cited by 92
Samuels, E. A., Baird, J. R., Yang, E. S., & Mello, M. J. (2018) · Academic Emergency Medicine · doi:10.1111/acem.13545 · Cited by 94
Green, T. C., Grau, L. E., Carver, H. W., Kinzly, M. L., & Heimer, R. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.007 · Cited by 90
McAuley, A., Aucott, L. S., & Matheson, C. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2015.09.011 · Cited by 90
Bachhuber, M. A., McGinty, E. E., Kennedy‐Hendricks, A., Niederdeppe, J., & Barry, C. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130050 · Cited by 90
Rech, M. A., Barbas, B., Chaney, W., Greenhalgh, E., & Turck, C. J. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.02.015 · Cited by 92
Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study
Bennett, A. S., Freeman, R., Jarlais, D. C. D., & Aronson, I. D. (2020) · JMIR Formative Research · doi:10.2196/22411 · Cited by 89
Intranasal naloxone administration for treatment of opioid overdose
Robinson, A., & Wermeling, D. P. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp130798 · Cited by 87
Emergency Department‐based Opioid Harm Reduction: Moving Physicians From Willing to Doing
Samuels, E. A., Dwyer, K. H., Mello, M. J., Baird, J. R., Kellogg, A. R., & Bernstein, E. (2016) · Academic Emergency Medicine · doi:10.1111/acem.12910 · Cited by 86
Emergency Medical Services Naloxone Access: A National Systematic Legal Review
Davis, C. S., Southwell, J. K., Niehaus, V. R., Walley, A. Y., & Dailey, M. W. (2014) · Academic Emergency Medicine · doi:10.1111/acem.12485 · Cited by 84
Rowe, C. L., Santos, G., Vittinghoff, E., Wheeler, E., Davidson, P. J., & Coffin, P. O. (2015) · Addiction · doi:10.1111/add.12961 · Cited by 83
Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
Lim, J. K., Bratberg, J. P., Davis, C. S., Green, T. C., & Walley, A. Y. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000223 · Cited by 82
Effects of naloxone distribution to likely bystanders: Results of an agent-based model
Keane, C., Egan, J. E., & Hawk, M. E. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.02.008 · Cited by 82
Green, T. C., Black, R. A., Serrano, J. M. G., Budman, S. H., & Butler, S. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027244 · Cited by 81
Davis, C. S., Carr, D. H., Southwell, J. K., & Beletsky, L. A. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302638 · Cited by 79
The opioid abuse and misuse epidemic: Implications for pharmacists in hospitals and health systems
Cobaugh, D. J., Gainor, C., Gaston, C. L., Kwong, T. C., Magnani, B., McPherson, M. L., Painter, J. T., & Krenzelok, E. P. (2014) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140157 · Cited by 78
Kolla, G., & Strıke, C. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.09.012 · Cited by 79
Bessen, S. Y., Metcalf, S. A., Saunders, E. C., Moore, S. K., Meier, A., McLeman, B. M., Walsh, O., & Marsch, L. A. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.09.008 · Cited by 77
Preventing Opiate Overdose Deaths: Examining Objections to Take-Home Naloxone
Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2010.0935 · Cited by 73
Drainoni, M., Koppelman, E. A., Feldman, J. A., Walley, A. Y., Mitchell, P. M., Ellison, J. E., & Bernstein, E. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2268-z · Cited by 73
Mars, S. G., Fessel, J. N., Bourgois, P. I., Montero, F., Karandinos, G., & Ciccarone, D. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.06.032 · Cited by 72
A response to the opioid overdose epidemic: Naloxone nasal spray
Wermeling, D. P. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0092-0 · Cited by 70
Bennett, A. S., & Elliott, L. C. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.001 · Cited by 70
Langham, S., Wright, A., Kenworthy, J., Grieve, R., & Dunlop, W. (2018) · Value in Health · doi:10.1016/j.jval.2017.07.014 · Cited by 70
Green, T. C., Bowman, S. E., Zaller, N. D., Ray, M., Case, P., & Heimer, R. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2013.787099 · Cited by 67
The Emergency Department as an Opportunity for Naloxone Distribution
Gunn, A. H., Smothers, Z., Schramm‐Sapyta, N. L., Freiermuth, C. E., MacEachern, M., & Muzyk, A. J. (2018) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2018.8.38829 · Cited by 64
Ryan, S. A., & Dunne, R. (2018) · Pain Management · doi:10.2217/pmt-2017-0060 · Cited by 67
The Bell Tolls for Thee & Thine: Compassion Fatigue & the Overdose Epidemic
Winstanley, E. L. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102796 · Cited by 66
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue
Wilson, L. M., & Castle, J. R. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818757795 · Cited by 64
Preventing opioid overdose with peer-administered naloxone: findings from a rural state
Hanson, B. L., Porter, R. R., Zöld, A. L., & Terhorst-Miller, H. (2020) · Harm Reduction Journal · doi:10.1186/s12954-019-0352-0 · Cited by 62
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose
Dietze, P., JAUNCEY, M. E., Salmon, A. M., Mohebbi, M., Latimer, J., van Beek, I., McGrath, C., & Kerr, D. C. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14977 · Cited by 61
Zaller, N. D., Yokell, M. A., Green, T. C., Gaggin, J., & Case, P. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2013.793355 · Cited by 60
Jones, J. D., Roux, P., Stancliff, S., Matthews, W., & Comer, S. D. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.05.006 · Cited by 62
Winstanley, E. L., Mahoney, J. J., Castillo, F., & Comer, S. D. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108838 · Cited by 66
Wagner, K. D., Liu, L., Davidson, P. J., Cuevas-Mota, J., Armenta, R. F., & Garfein, R. S. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.05.026 · Cited by 57
Oxytocin under opioid antagonism leads to supralinear enhancement of social attention
Dal Monte, O., Piva, M., Anderson, K. M., Tringides, M., Holmes, A. J., & Chang, S. W. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702725114 · Cited by 55
Neale, J., Brown, C., Campbell, A. N. C., Jones, J. D., Metz, V. E., Strang, J., & Comer, S. D. (2018) · Addiction · doi:10.1111/add.14510 · Cited by 55
Samuels, E. A. (2014) · PubMed · Cited by 55
Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study
Marshall, C., Perreault, M., Archambault, L., & Milton, D. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.11.015 · Cited by 58
Lewis, C., Vo, H. T., & Fishman, M. J. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s101700 · Cited by 54
Impacts of an opioid overdose prevention intervention delivered subsequent to acute care
Banta‐Green, C. J., Coffin, P. O., Merrill, J. O., Sears, J. M., Dunn, C. W., Floyd, A. S., Whiteside, L., Yanez, N. D., & Donovan, D. M. (2018) · Injury Prevention · doi:10.1136/injuryprev-2017-042676 · Cited by 53
Watson, D. P., Ray, B. R., Robison, L., Huynh, P., Sightes, E., Walker, L. S., Brucker, K., & Duwve, J. M. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0226-x · Cited by 51
What is known about community pharmacy supply of naloxone? A scoping review
Nielsen, S., & Hout, M. C. V. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.02.006 · Cited by 51
Strang, J., McDonald, R., Alqurshi, A. A., Royall, P. G., Taylor, D. M., & Forbes, B. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.042 · Cited by 51
Coffin, P. O., & Sullivan, S. D. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.811080 · Cited by 50
Treating Addictions: Harm Reduction in Clinical Care and Prevention
Drucker, E., Anderson, K., Haemmig, R., Heimer, R., Small, D., Walley, A., Wood, E., & van Beek, I. (2016) · Journal of Bioethical Inquiry · doi:10.1007/s11673-016-9720-6 · Cited by 49
Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic
Klebacher, R., Harris, M. I., Ariyaprakai, N., Tagore, A., Robbins, V., Dudley, L. S., Bauter, R., Koneru, S., Hill, R. D., Wasserman, E., et al. (2017) · Prehospital Emergency Care · doi:10.1080/10903127.2017.1335818 · Cited by 52
Expanded Access to Opioid Overdose Intervention: Research, Practice, and Policy Needs
Compton, W. M., Volkow, N. D., Throckmorton, D. C., & Lurie, P. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-1-201301010-00013 · Cited by 48
How do naloxone-based interventions work to reduce overdose deaths: a realist review
Miller, N., Waterhouse‐Bradley, B., Campbell, C., & Shorter, G. W. (2022) · Harm Reduction Journal · doi:10.1186/s12954-022-00599-4 · Cited by 43
Leece, P., Hopkins, S., Marshall, C., Orkin, A. M., Gassanov, M. A., & Shahin, R. (2013) · Canadian Journal of Public Health · doi:10.17269/cjph.104.3788 · Cited by 44
Law Enforcement Attitudes towards Naloxone following Opioid Overdose Training
Purviance, D., Ray, B. R., Tracy, A., & Southard, E. P. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1219439 · Cited by 44
Prescribing Naloxone for Opioid Overdose Intervention
Dunne, R. (2018) · Pain Management · doi:10.2217/pmt-2017-0065 · Cited by 45
Pharmacokinetics of a new, nasal formulation of naloxone
Tylleskär, I., Skulberg, A. K., Nilsen, T., Skarra, S., Jansook, P., & Dale, O. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2191-1 · Cited by 41
Friedman, J. R., Bourgois, P. I., Godvin, M., Chavez, A., Pacheco, L., Segovia, L. A., Beletsky, L. A., & Arredondo, J. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103678 · Cited by 43
Richert, T. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.07.006 · Cited by 41
Expanding access to naloxone in the United States
Doyon, S., Aks, S. E., & Schaeffer, S. E. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.968657 · Cited by 40
Furlan, A. D., Carnide, N., Irvin, E., Eerd, D. V., Munhall, C., Kim, J., Li, C. M. F., Hamad, A. H., Mahood, Q., & MacDonald, S. (2018) · Canadian Journal of Pain · doi:10.1080/24740527.2018.1479842 · Cited by 39
Metadata
- Authors
- Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P.
- Affiliations
- Boston University (US)
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2009-05
- Volume
- 99
- Issue
- 5
- Pages
- 788-791
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- PMC
- PMC2667836
- OpenAlex
- W2160243203
- Cited by
- 250
- References
- 25
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 9 · 2023: 9 · 2022: 19 · 2021: 20 · 2020: 13 · 2019: 17 · 2018: 20 · 2017: 19 · 2016: 25 · 2015: 22 · 2014: 22 · 2013: 14 · 2012: 9
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Public Health (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- intranasal naloxone, opioid overdose, overdose reversal, bystander intervention, public health regulation, harm reduction, opioid use disorder
- MeSH terms
- Administration, Intranasal, Adult, Emergency Medical Services, Female, Humans, Male, Naloxone, Narcotic Antagonists, Opioid-Related Disorders, Risk Factors, Program Evaluation, Needle-Exchange Programs, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review